Preparation, characterization and in vitro antiviral activity evaluation of foscarnet-chitosan nanoparticles
- 1 June 2014
- journal article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 118, 117-125
Abstract
No abstract availableKeywords
Funding Information
- Università di Genova
This publication has 30 references indexed in Scilit:
- Inhibition of Human Respiratory Syncytial Virus Infectivity by a Dendrimeric Heparan Sulfate-Binding PeptideAntimicrobial Agents and Chemotherapy, 2012
- Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosanInvestigational New Drugs, 2009
- Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of ZidovudineJournal of Microencapsulation, 2009
- Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administrationExperimental Eye Research, 2009
- Poly(γ,l-glutamic acid)–cisplatin conjugate effectively inhibits human breast tumor xenografted in nude miceBiomaterials, 2006
- Antiviral drugs for cytomegalovirus diseasesAntiviral Research, 2006
- Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosisBiochemical Journal, 2004
- A review of chitin and chitosan applicationsReactive and Functional Polymers, 2000
- Pharmacology and clinical use of foscarnetInternational Journal of Antimicrobial Agents, 1995
- Antiviral effects of phosphonoformate (pfa, foscarnet sodium)Pharmacology & Therapeutics, 1989